T. Rowe Price Investment Management, Inc.
Position in WGS — GeneDx Holdings Corp.
CIK 1897612
BALTIMORE, MD
Position in WGS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,528,186
-$70,446,363 QoQ
Shares Held
86,082
-85.3% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in WGS Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026T. Rowe Price Investment Management, Inc. holds $6,542,644,824 across 13 Diagnostics & Research names. WGS ranks #12 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVTY |
Revvity, Inc.
|
22,198,422 | $1,944,803,751 | |
| 2 | WAT |
Waters Corp /De/
|
4,663,879 | $1,388,903,166 | |
| 3 | A |
Agilent Technologies, Inc.
|
8,992,649 | $1,024,982,133 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
732,053 | $923,265,243 | |
| 5 | DHR |
Danaher Corp /De/
|
3,784,809 | $717,599,786 | |
| 6 | NTRA |
Natera, Inc.
|
1,130,820 | $226,152,691 | |
| 7 | SHC |
Sotera Health Co
|
9,125,621 | $130,861,405 | |
| 8 | GH |
Guardant Health, Inc.
|
755,707 | $69,804,655 |
All Filings in WGS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,528,186 | 86,082 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $75,974,549 | 584,150 | Shares | Sole | 2026-02-19 | |
| 2025-09-30 | $77,357,643 | 718,003 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $95,736,177 | 1,037,116 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $44,613,113 | 503,733 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||